Search Results

Showing results 121 - 130 of 3355.
Sort By: Date ▼

New HIV-prevention drug gets FDA approval—but not for cisgender women

October 14, 2019


FDA earlier this month approved Gilead Science's Descovy to prevent HIV infection in men and transgender women, and some critics are taking issue with the agency's decision to approve the drug before Gilead tested it on a large scale in cisgender women.

New FDA guidance outlines how drugmakers can co-develop cancer drugs with a diagnostic device

October 14, 2019


FDA on Wednesday took another step toward advancing so-called "precision medicine" by finalizing guidance detailing how drugmakers developing cancer drugs can incorporate risk assessments from unapproved diagnostic tests into their clinical trial applications.

What it's like to survive the mysterious, vaping-linked lung illness

October 11, 2019


After vaping for years, 18-year-old Piper Johnson spent a week in the intensive care unit with a lung illness officials say is linked to e-cigarette use and vaping—and now, as cases of the illness continue to rise, she is warning other teenagers of the risks and urging them to kick their vaping habit.

Colorado unveils its plan for a state public option—and it could cut provider payments

October 11, 2019


Colorado officials on Monday released a draft report outlining a proposed state public health insurance option, but the plan is drawing criticism from health care providers who would receive lower reimbursements under the proposal.

Nuns ask SCOTUS to review block on Trump contraceptive coverage rules

October 11, 2019


The Little Sisters of the Poor, an order of nuns, last week asked the Supreme Court to review a ruling by a federal appeals court that blocks the Trump administration's exemptions to the Affordable Care Act's contraceptive coverage rules.

How HHS wants to update anti-kickback rules to support value-based care

October 10, 2019


HHS on Wednesday issued long-anticipated proposed rules to update anti-kickback and physician-referral regulations so they do not interfere with physicians' ability to participate in value-based payment arrangements.

Jury orders J&J to pay patient $8B over antipsychotic Risperdal

October 10, 2019


A Philadelphia jury on Tuesday ordered New Jersey-based Johnson & Johnson (J&J) to pay $8 billion in punitive damages to a Maryland man who claimed J&J failed to properly warn patients and providers that its antipsychotic drug Risperdal could spur breast growth in boys.

Why the US won't be affected by the latest Zantac recall

October 10, 2019


GlaxoSmithKline on Tuesday announced that it is recalling the common heartburn drug Zantac in all markets as a "precaution," after FDA last week announced that it has detected "unacceptable" levels of a cancer-causing chemical in some samples of the drug—but the recall will not affect Zantac products sold in the United States.

The US 'wastes' nearly $1 trillion in health spending each year. Where does it all go?

October 9, 2019


About 25% of U.S. health care spending annually is wasteful, according to a study published Monday in JAMA. See where all the money goes on our interactive charts.

Results Page: [Previous] ... 11 12 13 14 15  ... [Next]